Clinical trial
Lexapro and Pramipexole and to Treat Major Depression
NCT00086307 · National Institute of Mental Health (NIMH), NIH · Completed
Key facts
| NCT number | NCT00086307 |
|---|---|
| Title | Lexapro and Pramipexole and to Treat Major Depression |
| Official title | Combining a Dopamine Agonist and Selective Serotonin Reuptake Inhibitor for Treatment of Depression: A Double-Blind, Randomized Study |
| Lead sponsor | National Institute of Mental Health (NIMH), NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Major Depression |
| Intervention type | Drug |
| Interventions | Pramipexole, Escitalopram |
| Enrollment | 39 |
| Start date | Jun 1, 2004 |
| Primary completion | Mar 1, 2010 |
| Completion | Mar 1, 2010 |
| First posted | Jun 30, 2004 |
| Last update posted | Jan 28, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: